Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction

NCT01956526 is registered in ClinicalTrials.gov with CorAssist Cadiovascular Ltd. as lead sponsor.

NCT NCT01956526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01956526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction
Lead sponsor
CorAssist Cadiovascular Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2013
Completion date
September 30, 2017
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction secondary to aortic stenosis, diastolic heart failure nyha class iii-iv